Benzinga | Jan 3, 2022 08:03AM EST

Biotech Acquisition Company Announces Confidential Submission Of Registration Statement On Form S-4 Related To Proposed Merger With Blade Therapeutics

Biotech Acquisition Company (NASDAQ:BIOT) ("BAC"), a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, today announced that it has made a confidential submission to the United States Securities and Exchange Commission ("SEC"), for receipt by the SEC on December 27, 2021, of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based in South San Francisco, CA.